A conversation: Polypharmacy in the nursing home

Journal of the American Medical Directors Association

Volumn 11, Issue 4, 2010, Pages 296-297

  Miles, Richard W ^a  

^a Medical Director of 6 long term care facilities in Benton and Washington Counties   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ELDERLY CARE; HEALTH CARE QUALITY; HIGH RISK POPULATION; HUMAN; LETTER; MEDICATION ERROR; NURSING HOME; POLYPHARMACY; RISK BENEFIT ANALYSIS;

EID: 77952488321     PISSN: 15258610     EISSN: 15389375     Source Type: Journal    
DOI: 10.1016/j.jamda.2010.01.001     Document Type: Letter

References (11)

1. Morley J.E. Polypharmacy in the nursing home. J Am Med Dir Assoc 2009, 10:289-291.
2. Gurwitz J.H. Polypharmacy: A new paradigm for quality drug therapy in the elderly. Arch Intern Med 2004, 164:1957-1958.
3. Tangalos E.D., Zarowitz B.J. Combination drug therapy. J Am Med Dir Assoc 2005, 8:406-409.
4. Cohn J.N. The fallacy of the mean. J Card Fail 2001, 7:103-104.
5. Stevenson L. Challenges for the basis of practice in heart failure. Circ Heart Fail 2008, 1:81-83.
6. Morley J.E. Phronesis and the medical director. J Am Med Dir Assoc 2009, 10:149-152.
7. Taleb N. The Black Swan: The Impact of the Highly Improbable 2007, Random House, New York.
8. Wharam J.S., Sulmasy D. Improving the quality of health care: Who is responsible for what?. JAMA 2009, 301:215-217.
9. Aristotle I.T. Nichomachean Ethics 1999, Hackett Publishing Company, Indianapolis, IN.
10. Katz P., Jurgisn K., Intrator O., Mor V. Nursing home physician specialists: A response to the workforce crisis in long-term care. Ann Intern Med 2009, 150:411-413.
11. Gladwell M. Outliers: The Story of Success 2008, Little Brown and Company, New York.